The AMCP Foundation and its partners have announced the winners of the 23rd Annual National Student Pharmacist Pharmacy & Therapeutics Competition, where teams from across the country developed a drug monograph and recommendations for formulary placement. The University of Connecticut School of Pharmacy took first place, followed by the University of Washington School of Pharmacy and the University of Minnesota College of Pharmacy.
Congratulations to Bilqees Fatima, Adaeze Amaefule, and Yuqi Lan, the recipients of AMCP Foundation’s Best Poster Awards at AMCP 2023. This semiannual competition, proudly presented by AMCP Foundation with support from CVS Health, culminates twice a year at AMCP national meetings.
HIV, or Human Immunodeficiency Virus, is a retrovirus that attacks the immune system, leading to a progressive weakening of the body's natural defenses against infections and diseases.
On March 31, AMCP submitted comments following a Feb. 2 proposed rule by the Internal Revenue Service, Employee Benefits Security Administration, and CMS regarding coverage of certain preventive services under the Affordable Care Act (ACA). In the comment letter, AMCP expresses support for the Departments' goals to increase access to preventive services.
On March 31, AMCP joined 10 other pharmacy organizations in a joint letter to Anne Milgram, Director of the U.S. Drug Enforcement Agency (DEA). The joint letter requests that the DEA extend flexibilities for telehealth prescribing of buprenorphine using the opioids-related public health emergency.
This sponsored webinar provides an overview of the impact and burden of Hepatitis C virus in the US, treatment landscape, elimination progress, access restrictions and the health economics of curative treatment.
AMCP welcomes the introduction of the Equitable Community Access to Pharmacist Services Act of 2023. This legislation would help improve health equity and combat public health threats.
